IP Library Granted Patent US 9,597,358
Granted Patent B2
US 9,597,358 · App. 13/581,707 · Granted Mar 21, 2017

Bioengineered human corneal stromal tissue

Inventors: Yiqin Du (Pittsburgh, PA); James L. Funderburgh (Pittsburgh, PA); William R. Wagner (Wexford, PA); Jian Wu (Pittsburgh, PA)
Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
A61K35/30C12N5/0068C12N5/0667C12N5/0668C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,597,358
App. No.
13/581,707
Granted
Mar 21, 2017
Kind
B2
Abstract

Provided herein is a method of making an aligned ECM scaffold useful in refractive correction of the eye and repair of the cornea. Methods of use of the scaffold as well as a scaffold construct are provided.

Claims (19)

1. A method of preparing an aligned extracellular matrix (ECM) scaffold comprising culturing functional keratocytes on a template scaffold comprising one or more layers comprising aligned fibers of a biocompatible, biodegradable polymeric composition for a length of time sufficient for the cells to produce a product ECM scaffold having oriented fibers, wherein the biocompatible, biodegradable polymeric composition comprises:

a polyurethane, a polyester, a polyether, a polyacrylamide, and/or a polycarbonate;

a polyurethane, a polyester, a polyether, a polyacrylamide, and/or a polycarbonate-containing block copolymer, or

a copolymer formed from one or more acrylic monomers, acrylamide monomers, succinimide monomers, glycolide monomers, caprolactone monomers, dioxanone monomers, lactide monomers, and/or carbonate monomers, and

wherein the template scaffold degrades so that the product ECM scaffold does not contain the biocompatible, biodegradable polymeric composition of the template scaffold.

2. The method of claim 1 , in which the biocompatible, biodegradable polymeric composition comprises a poly(ester urethane) urea elastomer.

3. The method of claim 1 , in which the biocompatible, biodegradable polymeric composition comprises a polymer composition having a Lower Critical Solution Temperature of 35° C. or less.

4. The method of claim 3 , in which the biocompatible, biodegradable polymeric composition comprises poly(N isopropyl acrylamide).

5. The method of claim 1 , in which the template scaffold comprises a plurality of the one or more layers and wherein, the aligned fibers of a first layer of the plurality of the one or more layers are arranged at a different angle with respect to the aligned fibers of a second layer of the plurality of the one or more layers that is adjacent to the first layer.

6. The method of claim 5 , in which the aligned fibers of a first layer of the plurality of layers are arranged at a 20° to 90° angle with respect to the aligned fibers of a second layer of the plurality of the one or more layers that is adjacent to the first layer.

7. The method of claim 1 , further comprising preparing the template scaffold by electrospinning the biocompatible, biodegradable polymeric composition to prepare the aligned fibers of the one or more layers.

8. The method of claim 1 , further comprising preparing the template scaffold by seeding one or more of the one or more layers with functional keratocytes or functional keratocyte precursors that are differentiated on the template scaffold to produce the functional keratocytes.

9. The method of claim 8 , in which the one or more layers comprises a plurality of layers and further comprising stacking the one or more layers so that at least one layer is arranged so that its fibers are oriented at a different angle with respect to fibers of an adjacent layer.

10. The method of claim 8 , in which the functional keratocytes or functional keratocyte precursors are seeded by electrospraying.

11. The method of claim 8 , in which the functional keratocytes or functional keratocyte precursors are seeded by depositing cells onto the one or more layers in culture.

12. The method of claim 8 , in which the functional keratocyte precursors are corneal stroma stem cells.

13. The method of claim 8 , in which the functional keratocyte precursors are adipose-derived stem cells.

14. The method of claim 1 , further comprising decellularizing the product ECM scaffold.

15. The method of claim 1 , wherein the biocompatible, biodegradable polymeric composition comprises a polyurethane, a polyester, or a polymer composition having a Lower Critical Solution Temperature of 35° C. or less.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2012
From: DU, YIQIN; FUNDERBURGH, JAMES L.; WAGNER, WILLIAM R.; WU, JIAN
To: UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
Reel/Frame 029270/0419 →
CONFIRMATORY LICENSE Recorded Oct 26, 2012
From: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029199/0099 →
Continuity (2)
Provisional Application 61310559 · Mar 4, 2010
Related Publication 20130209571A1 · Aug 15, 2013